Company: WELNF
Filing Date: 2025-11-12
Form Type: DEFM14A
Source: 0001104659-25-109577
Chunk: 247

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-11-12
Form: DEFM14A
Chunk 247
---
 of a Company Material Adverse Effect (as defined in the Business Combination Agreement), (iv) the Btab Reorganization being completed, and (v) the delivery of customary closing certificates and transaction documents.

The obligation of Btab to consummate the Transactions is also subject to the satisfaction or waiver of other closing conditions, including, but not limited to, (i) the representations and warranties of IWAC and Merger Sub being true and correct to the standards applicable to such representations and warranties, (ii) each of the covenants of IWAC required to be completed at or prior to the Closing having been performed or complied with in all material respects, (iii) the approval by the NYSE of the listing of the Pubco Class A Shares to be issued in connection with the Mergers, (iv) the Domestication having been consummated on the Closing Date prior to the Company Merger Effective Time, and (v) the delivery of customary closing certificates and transaction documents.

If permitted under applicable law, either IWAC or Btab may waive in writing any conditions for the benefit of itself contained in the Business Combination Agreement. If any of the conditions to a party’s obligation to consummate the Mergers is not satisfied or waived in writing by such party, then such party will not be required to consummate the Mergers.

#### Termination
The Business Combination Agreement may be terminated under certain customary and limited circumstances prior to the Closing, including, but not limited to:

(i)

by mutual written consent of IWAC and Btab;

(ii)

by IWAC, if Btab breaches its representations, warranties and covenants in the Business Combination Agreement such that the closing conditions would not be satisfied (subject to a cure period);

(iii)

by Btab, if IWAC breaches its representations, warranties and covenants in the Business Combination Agreement such that the closing conditions would not be satisfied (subject to a cure period);

(iv)

subject to certain limited exceptions, by either IWAC or Btab if the Mergers are not consummated by the date that is the last date for IWAC to consummate its initial business combination in accordance with its governing documents (after giving effect to any Charter Extension Amendments);

(v)

by either IWAC or Btab, if the requisite approval by IWAC shareholders of the Required Purchaser Shareholder Approval (as defined in the Business Combination Agreement) was not obtained;

(vi)

by either IWAC or Btab, if a governmental order permanently enjoining, restraining